With a variety of post-cataract NSAIDs available, why choose PROLENSA®? In this video, our panel of ophthalmologists and their staff break down why they choose PROLENSA® to help treat their patients’ post-cataract surgery inflammation and pain.
Please see Indication and Important Safety Information below
Download and share these resources with your practice and patients.
PROLENSA® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
Click here for full prescribing information on PROLENSA®
PROLENSA is a trademark of Bausch & Lomb Incorporated or its affiliates. Any other products/brand names are trademarks of the respective owners.